Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer Using whole exome sequencing data from primary tumors in The Cancer Genome ...
To understand the clinical context of tumor mutational burden (TMB) when comparing a pan-cancer threshold and a cancer-specific threshold. MATERIALS AND METHODS Using whole exome sequencing data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results